Source:http://linkedlifedata.com/resource/pubmed/id/11475804
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-7-30
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0040-5957
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
257-60
|
pubmed:dateRevised |
2006-10-30
|
pubmed:meshHeading | |
pubmed:articleTitle |
[At which moment should one introduce Therapeutic Drug Monitoring into emergent therapy].
|
pubmed:affiliation |
Service de pharmacologie, Centre Hospitalier et Universitaire Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, 47 à 83 boulevard de l'Hôpital 75013 Paris, France.
|
pubmed:publicationType |
Journal Article
|